These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1575137)

  • 1. Short- and long-term antiarrhythmic and hemodynamic effects of d,l-sotalol in patients with symptomatic ventricular arrhythmias.
    Hohnloser SH; Zabel M; Krause T; Just H
    Am Heart J; 1992 May; 123(5):1220-4. PubMed ID: 1575137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of sotalol in patients with complex ventricular arrhythmias.
    Hohnloser SH; Zabel M; van de Loo A; Klingenheben T; Just H
    Int J Cardiol; 1992 Dec; 37(3):283-91. PubMed ID: 1281807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmias.
    Anastasiou-Nana MI; Gilbert EM; Miller RH; Singh S; Freedman RA; Keefe DL; Saksena S; MacNeil DJ; Anderson JL
    Am J Cardiol; 1991 Mar; 67(6):511-6. PubMed ID: 1705386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term antiarrhythmic efficacy and safety of d-sotalol in patients with ventricular tachycardia and a low ejection fraction.
    Koch KT; Düren DR; van Zwieten PA
    Cardiovasc Drugs Ther; 1995 Jun; 9(3):437-43. PubMed ID: 8527354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of sotalol on heart rate variability in patients with symptomatic, complex ventricular arrhythmias].
    Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Apr; 83(4):293-8. PubMed ID: 8023542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.
    Fitton A; Sorkin EM
    Drugs; 1993 Oct; 46(4):678-719. PubMed ID: 7506652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
    Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with sotalol in the treatment of cardiac arrhythmias.
    Kirschenbaum HL; Rosenberg JM
    Clin Ther; 1994; 16(3):346-64. PubMed ID: 7923303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hemodynamic effects of sotalol and quinidine: analysis by use of rest and exercise gated radionuclide angiography.
    Mahmarian JJ; Verani MS; Hohmann T; Hill R; Thornton BC; Bolli R; Young JB; Roberts R; Pratt CM
    Circulation; 1987 Aug; 76(2):324-31. PubMed ID: 3301053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses.
    Anderson JL; Askins JC; Gilbert EM; Miller RH; Keefe DL; Somberg JC; Freedman RA; Haft LR; Mason JW; Lessem JN
    J Am Coll Cardiol; 1986 Oct; 8(4):752-62. PubMed ID: 2428852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of d-sotalol, a pure class III antiarrhythmic compound, in patients with symptomatic complex ventricular ectopy. Results of a multicenter, randomized, double-blind, placebo-controlled dose-finding study. The d-Sotalol PVC Study Group.
    Hohnloser SH; Meinertz T; Stubbs P; Crijns HJ; Blanc JJ; Rizzon P; Cheuvart B
    Circulation; 1995 Sep; 92(6):1517-25. PubMed ID: 7664435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term sotalol therapy in patients with ventricular arrhythmias.
    Mary-Rabine L; Soumagne D; Stiels B
    Acta Cardiol; 1986; 41(2):89-97. PubMed ID: 2424202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between ventricular function and antiarrhythmic responses to sotalol.
    Singh SN; Chen YW; Cohen A; Obeid M; Tracy C; Woosley RL; Fletcher RD
    Am J Cardiol; 1989 Oct; 64(14):943-5. PubMed ID: 2801566
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term experience with sotalol in the treatment of complex ventricular arrhythmias.
    Anastasiou-Nana MI; Anderson JL; Askins JC; Gilbert EM; Nanas JN; Menlove RL
    Am Heart J; 1987 Aug; 114(2):288-96. PubMed ID: 3604885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.
    Nademanee K; Feld G; Hendrickson J; Singh PN; Singh BN
    Circulation; 1985 Sep; 72(3):555-64. PubMed ID: 4017207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and proarrhythmia of oral sotalol in pediatric patients.
    Pfammatter JP; Paul T; Lehmann C; Kallfelz HC
    J Am Coll Cardiol; 1995 Oct; 26(4):1002-7. PubMed ID: 7560592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentre randomized trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias. Amiodarone vs Sotalol Study Group.
    Eur Heart J; 1989 Aug; 10(8):685-94. PubMed ID: 2676535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute echocardiographic effects of sotalol on ventricular systolic function in dogs with ventricular arrhythmias.
    Visser LC; Kaplan JL; Nishimura S; Gunther-Harrington CT; Bélanger C; Oldach MS; Stern JA; Mueller MS
    J Vet Intern Med; 2018 Jul; 32(4):1299-1307. PubMed ID: 29968936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sotalol in treatment of pediatric cardiac arrhythmias.
    Celiker A; Ayabakan C; Ozer S; Ozme S
    Pediatr Int; 2001 Dec; 43(6):624-30. PubMed ID: 11737739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.